Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties

Microvascular Research
Sho-ichi YamagishiT Imaizumi

Abstract

Angiotensin II (Ang II), the dominant effector of the renin-angiotensin system, elicits numerous inflammatory-proliferative responses, thereby being involved in angiogenesis. T cells play an important role in angiogenesis as well by delivering vascular endothelial growth factor (VEGF) to inflammatory sites. Since we have previously shown that pigment-epithelium-derived factor (PEDF) blocks the Ang II signaling in endothelial cells, we studied here whether PEDF could inhibit the Ang-II-induced VEGF expression in MOLT-3 T and examined the potential mechanism of PEDF inhibitory effects. Ang II significantly up-regulated VEGF mRNA levels in MOLT-3 T cells, which was inhibited by PEDF or olmesartan, an Ang II type 1 receptor blocker. PEDF blocked the Ang-II-induced reactive oxygen species (ROS) generation in MOLT-3 T cells. Furthermore, H(2)O(2) was found to up-regulate VEGF mRNA levels in MOLT-3 T cells in a dose-dependent manner. These results demonstrate that PEDF could inhibit the Ang-II-induced VEGF expression in MOLT-3 T cells via suppression of ROS generation. Blockade by PEDF of VEGF expression in T cells may become a novel therapeutic target for pathological angiogenesis.

References

Sep 1, 1991·Experimental Eye Research·J Tombran-TinkL V Johnson
Jul 4, 2003·The Journal of Clinical Investigation·Kimiyasu EgamiTsutomu Imaizumi
Mar 23, 2004·Current Drug Targets. Inflammation and Allergy·Claudia MonacoEwa Paleolog
Jun 24, 2004·British Journal of Pharmacology·Shu-Meng ChengJenn-Haung Lai
Dec 8, 2004·Current Cancer Drug Targets·Hitoshi YoshijiHiroshi Fukui

❮ Previous
Next ❯

Citations

Jul 24, 2010·Journal of Ophthalmology·Masayoshi TakeuchiSho-Ichi Yamagishi
Oct 29, 2013·Biochemical and Biophysical Research Communications·Takanori MatsuiSho-ichi Yamagishi
Dec 18, 2013·Biochemical and Biophysical Research Communications·Takanori MatsuiSho-ichi Yamagishi
Mar 21, 2019·Current Pharmaceutical Design·Sho-Ichi YamagishiMinoru Yagi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.